Moodley 2003.

Methods	Sequentially‐numbered, opaque envelopes.
Participants	400 women with indication for induction at any gestation, alive or dead and with any membrane status.
Interventions	3 groups. Oral miso 20 mcg 2‐hourly (max x 4) or dinoprostone 1 mg 6‐hourly (max x 3), or vaginal miso 25 mcg x 1 followed by oral misoprostol 20 mcg 2‐hourly (max x 3).
Outcomes	Labour and delivery outcomes. Neonatal outcomes.
Notes	Combined oral and vaginal misoprostol group not included in analysis.
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Low risk	A ‐ Adequate